Close

Analyst Ratings for Eleven Biotherapeutics (EBIO)

EBIO Rating Summary

  |   Expand Research on EBIO
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/10/2018 Laidlaw N/A New Coverage Buy
(N/A)
8.00
(N/A)
2.83
(3.29)
16.25% Details
3/20/2018 H.C. Wainwright N/A New Coverage Buy
(N/A)
2.00
(N/A)
1.05
(3.29)
213.33% Details
Like EBIO Ratings? Also take a look at

EBIO Ratings News